Buchumschlag

Validation of a blood protein signature for non-small cell lung cancer

CT screening for lung cancer is effective in reducing mortality, but there are areas of concern, including a positive predictive value of 4% and development of interval cancers. A blood test that could manage these limitations would be useful, but development of such tests has been impaired by varia...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Mehan, Michael R. (VerfasserIn) , Williams, Stephen A. (VerfasserIn) , Siegfried, Jill M. (VerfasserIn) , Bigbee, William L. (VerfasserIn) , Weissfeld, Joel L. (VerfasserIn) , Wilson, David O. (VerfasserIn) , Pass, Harvey I. (VerfasserIn) , Rom, William N. (VerfasserIn) , Muley, Thomas (VerfasserIn) , Meister, Michael (VerfasserIn) , Franklin, Wilbur (VerfasserIn) , Miller, York E. (VerfasserIn) , Brody, Edward N. (VerfasserIn) , Ostroff, Rachel M. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 1 August 2014
In: Clinical proteomics
Year: 2014, Jahrgang: 11
ISSN:1559-0275
DOI:10.1186/1559-0275-11-32
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/1559-0275-11-32
Volltext
Verfasserangaben:Michael R. Mehan, Stephen A. Williams, Jill M. Siegfried, William L. Bigbee, Joel L. Weissfeld, David O. Wilson, Harvey I. Pass, William N. Rom, Thomas Muley, Michael Meister, Wilbur Franklin, York E. Miller, Edward N. Brody and Rachel M. Ostroff
Beschreibung
Zusammenfassung:CT screening for lung cancer is effective in reducing mortality, but there are areas of concern, including a positive predictive value of 4% and development of interval cancers. A blood test that could manage these limitations would be useful, but development of such tests has been impaired by variations in blood collection that may lead to poor reproducibility across populations.
Beschreibung:Gesehen am 16.02.2021
Beschreibung:Online Resource
ISSN:1559-0275
DOI:10.1186/1559-0275-11-32

Ähnliche Einträge